Calcium channel blocker-induced gingival enlargement.

Area of Science:

• Dentistry
• Pharmacology

Background:

• Calcium channel blockers (CCBs) are widely prescribed antihypertensive medications.
• Their significant oral side effects, specifically gingival enlargement, are often overlooked.
• Drug-induced gingival enlargement impacts patient appearance and oral function.

Purpose of the Study:

• To review the etiology and risk factors of CCB-induced gingival enlargement.
• To describe the clinical manifestations of this condition.
• To outline the periodontal management strategies for affected patients.

Main Methods:

• Literature review on calcium channel blockers and gingival overgrowth.
• Analysis of clinical presentation and contributing factors.
• Evaluation of treatment options, including drug substitution and periodontal interventions.

Main Results:

• CCBs are frequently implicated in drug-induced gingival enlargement.
• Enlargement severity ranges from mild to severe, affecting aesthetics and function.
• Treatment necessitates drug cessation/substitution and potentially periodontal therapy.

Conclusions:

• Recognizing and managing CCB-induced gingival enlargement is crucial in dental practice.
• A multidisciplinary approach involving medical and dental professionals ensures optimal patient outcomes.
• Further research into prevention and treatment is warranted.